Clinical Trials
3
Active:0
Completed:1
Trial Phases
2 Phases
Early Phase 1:1
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Early Phase 1
1 (33.3%)Novel Supplement-based Therapy for the Treatment of Small Intestinal Bacterial Overgrowth
Early Phase 1
Withdrawn
- Conditions
- Small Intestinal Bacterial Overgrowth
- First Posted Date
- 2018-02-05
- Last Posted Date
- 2021-01-12
- Lead Sponsor
- Atrium Innovations
- Registration Number
- NCT03420976
- Locations
- 🇺🇸
Good Medicine, Oxford, Ohio, United States
The Safety and Efficacy of an Enzyme Combination in Managing Knee Osteoarthritis Pain in Adults
Phase 2
Completed
- Conditions
- WobenzymOsteoarthritis
- Interventions
- First Posted Date
- 2014-03-17
- Last Posted Date
- 2014-03-17
- Lead Sponsor
- Atrium Innovations
- Target Recruit Count
- 150
- Registration Number
- NCT02088411
- Locations
- 🇩🇪
Mucos Pharma GmbH & Co, Oberhaching, Germany
Multi-Center Study Evaluating the Efficacy of Wobenzym(R)N in Treating Knee Osteoarthritis
Phase 2
Withdrawn
- Conditions
- Knee Osteoarthritis
- First Posted Date
- 2009-09-10
- Last Posted Date
- 2016-07-12
- Lead Sponsor
- Atrium Innovations
- Registration Number
- NCT00974428
- Locations
- 🇨🇦
Institut de Rhumatologie de Montréal, Montreal, Quebec, Canada
🇨🇦Centre de Rhumatologie St-Louis, Sainte-foy, Quebec, Canada
🇨🇦Centre de Recherche Musculo-Squelettique, Trois-Rivieres, Quebec, Canada
News
No news found